Global Unit Case Volume Grew 5% Net Revenues Grew 7%;Organic Revenues (Non-GAAP) Grew 7% Operating Income Grew 12%;Comparable ...

Hibsago (bepirovirsen) approved in the US for the treatment of chronic hepatitis B (CHB) Approval based on phase III data ...

GSK Presents First Global Data for Ris-Rez in Extensive-Stage Small Cell Lung Cancer 61% overall response rate in phase Ib ...

James Halstead plc, the AIM listed manufacturer and international distributor of floor coverings, announces its results for the six months ended 31 December 2025.

UK markets moved into positive territory following a volatile week, with the FTSE 100 rising 0.33% to around 10,530 points at the time of writing. The Iran war has reportedly created a nearly £12 ...

UK markets pulled back this week, with the FTSE 100 Index falling 2.12% to trade at around 10,495 points at the time of writing. Despite the broader weakness, UK housebuilders rallied after the ...

* Like-for-like (LFL) company-managed shop sales performance against comparable period in 2025 In the third quarter of 2026, Greggs delivered 7.7% sales growth, with LFL sales in company-managed shops ...

Goodwin PLC provides the following update on trading for the four months ended 31 August 2026 (“the Period”), focusing on the businesses that will remain within the Group following completion of the ...